The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Cancer Policy

FDA advisory panel recommends first-of-its-kind mRNA flu vaccine for older adults

OMB draft rule politicizing research should be rescinded, House Dems urge in a letter to Bhattacharya

OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds

Early-onset cancer bill introduced in Congress

NIH calls for comment on proposal to limit the number of RPGs per PI

Federal judge blocks Trump policy to charge $100,000 fee for H1-B visas

Clinical Roundup

AACR releases 2026 Cancer Disparities Progress Report

Sigvotatug vedotin misses OS primary endpoint vs. docetaxel in phase III trial in previously treated metastatic non-squamous NSCLC

Mezigdomide + carfilzomib + dexamethasone regimen reduces disease progression in r/r MM, phase III trial finds

Researchers at Rutgers Cancer Institute and Rutgers Business School build simulation method to reduce cancer treatment times

TAMP procedure shows 52% reduction in pancreatic tumor metabolic activity, Moffitt case study shows

Sylvester researchers discover method of disrupting inflammatory network that helps pancreatic cancer resist treatment

In The Clinic
Trials & Tribulations

What NHS-Galleri taught us—and what it didn’t

Trials & Tribulations
FreeTrials & Tribulations
Trials & Tribulations

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account